Voyager Therapeutics CFO Peter Pfreundschuh to resign; Robin Swartz appointed as principal financial officer

Voyager Therapeutics, Inc.

CFO Peter Pfreundschuh resigns effective April 12, 2024; remains as Senior Financial Advisor until May 5, 2024.
Robin Swartz, current COO, appointed principal financial and accounting officer effective April 12.
Pfreundschuh receives salary continuation for 12 months, prorated 2024 bonus, and health insurance.
Unvested equity awards continue to vest during consulting period up to ~July 2024.
Separation Agreement includes release of claims and non-disparagement obligations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.